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ABSTRACT
Background and Objectives: EUS-guided biliary drainage (EUS-BD) is a feasible procedure when ERCP fails, as is 
percutaneous transhepatic BD (PTBD). However, little is known about patient perception and preference of EUS-BD and 
PTBD. Patients and Methods: An international multicenter survey was conducted in seven tertiary referral centers. In 
total, 327 patients, scheduled to undergo ERCP for suspected malignant biliary obstruction, were enrolled in the study. 
Patients received decision aids with visual representation regarding the techniques, benefits, and adverse events (AEs) 
of EUS-BD and PTBD. Patients were then asked the choice between the two simulated scenarios (EUS-BD or PTBD) 
after failed ERCP, the reasons for their preference, and whether altering AE rates would influence their prior choice. 
Results: In total, 313 patients (95.7%) responded to the questionnaire and 251 patients (80.2%) preferred EUS-BD. 
The preference of EUS-BD was 85.7% (186/217) with EUS-BD expertise, compared to 67.7% (65/96) without EUS-BD 
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INTRODUCTION
ERCP with biliary drainage (BD) is a standard 
procedure for malignant biliary obstruction.[1,2] However, 
ERCP may fail in certain patients due to failed 
transpapillary cannulation or an inaccessible papilla 
caused by the duodenal invasion of  the malignant 
tumor.[3-7] The failure rate of  ERCP is reported to be 
up to 7%,[8] and percutaneous transhepatic BD (PTBD) 
is a conventional option in such cases. PTBD has been 
demonstrated to have a high success rate (87%–100%).[9] 
However, the requisite external catheter placement is 
a major drawback, in addition to several adverse 
events (AEs) including pneumothorax, hepatic arterial 
injury, bile duct injury, and liver abscess.[10-12] As a result, 
many endoscopists sought to identify a less invasive 
procedure than PTBD.
Since the first report by Giovannini et al. in 2001,[13] 
EUS-guided BD (EUS-BD) has been reported to be 
a feasible and effective BD procedure when ERCP 
fails. EUS-BD has been demonstrated to have a 
technical success rate of  approximately 90% and an 
AE rate of  17%.[9,14-18] It has specific advantages over 
PTBD, as follows: (1) it can be performed in a single 
session when ERCP has been unsuccessful, (2) it can 
provide immediate internal drainage with less physical 
discomfort,[19] and (3) it is potentially cost-effective, 
with fewer unscheduled reintervention over long-term 
follow-up.[19,20] However, EUS-BD requires experienced 
endoscopists with advanced endoscopic capabilities and 
appropriate radiological/surgical backup to manage 
failed interventions and/or AEs.
Although endoscopists with EUS-BD expertise may 
prefer EUS-BD over PTBD after failed ERCP due 
to the potential benefits of  EUS-BD including a 
possible one-stage procedure in the same ERCP 
unit and internal drainage, patient perception and 
preference of  EUS-BD are not well understood. 
Since patients’  medical knowledge was l imited 
and personal patient preference had not been 
incorporated in medical decision-making, it was 
difficult to make patient-centered decision in real 
clinical practice. Recently, shared decision-making 
model between patient and physician has been 
suggested,[21,22] and patient decision aids which help 
appropriate informed choice has been evaluated.[23] 
Eliciting the personal preference of  the patient then 
working to align these values and preference with 
shared decision-making strengthens the therapeutic 
alliance and is more protective of  the provider in a 
medico-legal context.[24] Poor communication by the 
provider and inadequate knowledge on the part of  
the patient are often precursors for medical liability 
claim.[25]
The primary aim of  this study was to determine 
whether patients with suspected malignant biliary 
obstruction enrolled prefer EUS-BD or PTBD under 
a simulated scenario (after failed ERCP) with decision 
aids. The secondary aim was to assess whether altering 
AEs rates in EUS‑BD influenced the patient selection 
of  EUS-BD and/or PTBD.
PATIENTS AND METHODS
Study population
This study was an international multicenter 
cross-sectional survey of  patients scheduled to undergo 
ERCP for suspected malignant obstruction. Participation 
in the study was voluntary, and compensation was not 
provided. An informational booklet describing EUS-BD 
and PTBD as rescue procedures when ERCP fails, 
which contained details of  the techniques, benefits, 
and AEs relating to each procedure was provided to 
the study participants. Once the informational booklet 
was read, the survey was administered to consecutive 
patients.
expertise (P < 0.001). The main reason for choosing EUS-BD was the possibility of internal drainage (78.1%). In 
multivariate analysis, the availability of EUS-BD expertise was the single independent factor that influenced patient 
preference (odds ratio: 3.168; 95% of confidence interval, 1.714–5.856; P < 0.001). The preference of EUS-BD increased 
as AE rates decreased (P < 0.001). Conclusions: In this simulated scenario, approximately 80% of patients preferred 
EUS-BD over PTBD after failed ERCP. However, preference of EUS-BD declined as its AE rates increased. Further 
technical innovations and improved proficiency in EUS-BD for reducing AEs may encourage the use of this procedure 
as a routine clinical practice when ERCP fails.
Keywords: Drainage, endosonography, patient preference, surveys and questionnaires
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Seven tertiary referral centers in South Korea, Japan, 
and Spain were participated in this study. Of  these, 
EUS‑BD was available in five centers, and PTBD was 
available at all of  them. Participants who preferred 
EUS-BD were informed as to whether EUS-BD could 
be performed at their center. Along with the survey, 
informed consent to undergo any of  the available BD 
procedures (ERCP, EUS-BD, and PTBD) was obtained 
from the patients before ERCP. The institutional review 
board for each institution approved the study protocol.
Informational booklet and survey
A third party in the United States created the 
informational booklet [Supplementary Appendix 1] with 
visual aids and questionnaire [Supplementary Appendix 2] 
to minimize selection bias with respect to the 
endoscopists. The survey was simplified using a subject 
choice followed by an explanation choice model, and it 
was written in easily understandable 5th grade US English 
for patients without medical knowledge. In an attempt 
to create a reliable and valid questionnaire, the survey 
was first administered to 34 3rd-year medical students 
at the University of  Ulsan College of  Medicine, Seoul, 
South Korea, and pilot-tested for clarity and internal 
consistency [Supplementary Appendix 3]. As a result, 
the questionnaire demonstrated high internal consistency, 
with a Cronbach’s α value of  0.82. The forms then were 
translated into Korean, Japanese, and Spanish.
The survey was administered to the participants by 
trained research assistants who read from a standardized 
script. The patients were allowed sufficient time to read 
the information booklet and complete the questionnaire. 
A detailed explanation or discussion of  each procedure 
was not permitted to minimize the risk of  selection 
bias. It was clearly stated that the patient’s preference 
would not be disclosed to the attending physician and 
it would not affect the treatment plan. The results were 
blinded to ensure patient anonymity.
The questionnaire started with questions on age, 
sex, ethnicity, and prior endoscopy, ERCP, and 
PTBD [Supplementary Appendix 2]. First, participants 
were questioned as to their preference of  a rescue 
procedure (EUS-BD or PTBD) to be performed in 
the event of  failed ERCP and were asked to provide 
the reasons for their preference. Choice options listed 
for EUS-BD were as follows: (1) It can be done at 
the same time during the ERCP, so you do not have 
to come back again for another procedure, (2) It has a 
higher success rate and relatively low AEs, and (3) It 
is comfortable, so you do not have drain tube through 
the skin (such as PTBD). Choice options listed for a 
PTBD were as follows: (1) It takes less time to place 
it (quicker), (2) It is cheaper, (3) It is safer (lower AEs), 
and (4) It is more convenient (easy to perform for the 
operator). Patients were also permitted to write down 
any unlisted reasons for their preference.
Patients were then asked whether their opinion would 
change depending on altering AE rates of  EUS-BD 
compared to those of  PTBD (9%–33%). To reduce 
the chance of  selection bias among EUS-BD experts, 
two centers without EUS-BD experts (two South Korean 
centers), three centers with EUS-BD experts 
(one South Korea center and two Spanish centers), 
and two centers with experts in both EUS-BD and 
PTBD (two Japanese centers) were invited to participate.
Statistical analyses
The participants were divided into two groups 
according to the procedure of  their choosing (EUS-BD 
vs. PTBD). Statistical analysis was performed using 
SPSS software version 21.0 (SPSS Inc., Chicago, IL). 
Continuous variables were reported as the mean and 
standard deviation and were compared between the 
groups using the unpaired t-test. Categorical variables 
were reported as frequencies and percentages and 
were evaluated using Fisher’s exact test. The value of 
P < 0.05 was considered to be statistically significant.
To calculate the sample size, it was assumed that 
two-thirds (66%) of  the sample would prefer EUS-BD. 
A sample size of  75 was identified to determine 
whether this proportion was significantly different from 
50% a priori, with an alpha of  0.05 and a power of  
80%. Assuming a 30% response rate, we planned to 
recruit 350 patients (50 patients from each institution).
RESULTS
In total, 327 patients who were scheduled to undergo 
ERCP due to suspected malignant biliary obstruction 
were recruited and of  these, 313 patients completed 
the questionnaire (response rate: 95.7%) [Figure 1]. 
The demographic characteristics of  the study 
participants are shown in Table 1. The mean age 
was 64 years (range: 34–88 years), and 182 of  the 
respondents (58.1%) were male. The suspected 
diagnoses of  the respondents based on imaging 
studies (abdominopelvic computed tomography 
and/or magnetic resonance cholangiopancreatography) 
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For the second question, preference of  EUS-BD 
decreased as AE rates increased (P < 0.001). 
Two-hundred and one of  217 participants (92.6%) at 
the five centers with EUS‑BD expertise were willing to 
undergo PTBD if  AE rates of  EUS-BD were higher 
than those of  PTBD (range: 9%–33%). In contrast, 
if  AE rates of  EUS-BD were lower when compared 
to those of  PTBD, 93 of  96 participants (96.9%) 
at the two centers without EUS-BD expertise 
were willing to undergo EUS-BD. There was no 
significant difference in patient preference based on 
AE rates of  EUS-BD according to the availability 
of  EUS-BD expertise [Figure 3a] or the region 
(Asia vs. Europe) [Figure 3b].
DISCUSSION
To the best of  our knowledge, this is the first study to 
focus on the patient preference of  BD procedures in 
patients with suspected malignant biliary obstruction. 
In this survey, most patients would prefer EUS-BD to 
PTBD when ERCP fails due to the ability to undergo 
internal drainage without the need for a percutaneous 
drain tube. Preference of  EUS-BD was significantly 
higher at centers with EUS-BD expertise compared to 
centers without EUS-BD expertise (85.7% vs. 67.7%, 
respectively; P < 0.001). In multivariate analysis, the 
availability of  EUS-BD expertise was significantly 
associated with the preference of  EUS-BD (OR 3.168, 
95% CI 1.714–5.856, P < 0.001). In addition, patient 
willingness to undergo EUS-BD was observed to 
decline in the context of  higher AE rates compared 
to PTBD.
EUS-BD has been reported to be a feasible BD 
technique. In a recent randomized controlled trial, 
EUS-BD was compared with PTBD after failed ERCP 
in patients with malignant biliary obstruction.[26] In 
that study, EUS-BD showed technical success rates 
comparable to those of  PTBD (94.1% vs. 96.9%, 
respectively), and fewer AE rates compared to 
PTBD (8.8% vs. 31.2%, respectively). Although detailed 
data on EUS-BD are limited, there are clear advantages 
to EUS-BD, including the possibility of  internal 
drainage without the placement of  a percutaneous drain 
tube, and the fact that EUS-BD can be performed 
in the same session after failed ERCP provided 
appropriate informed consent is obtained.
In this study, before ERCP, patients were asked about 
preferred BD procedure when ERCP fails. This 
were cholangiocarcinoma in 101 (32.3%), gallbladder 
cancer in 25 (8%), ampullary cancer in 20 (6.4%), 
pancreatic head cancer in 93 (29.7%), hepatocellular 
carcinoma in seven (2.2%), metastatic lymph node 
in five (1.6%), and indeterminate biliary stricture in 
62 (19.8%).
Among these, 258 patients (82.4%) had previously 
undergone endoscopy, 163 patients (52.1%) had 
undergone ERCP, and 55 patients (17.6%) had 
undergone PTBD. There were no differences in 
preference between EUS-BD and PTBD within three 
subgroups. EUS-BD was preferred by 186 of  217 
participants (85.7%) at the five centers which EUS‑BD 
was available, compared to 65 of  96 patients (67.7%) 
at the two centers which it was unavailable (P < 0.001). 
There was no significant difference in preference of  
EUS-BD according to the region (Asia vs. Europe) or 
race (Asian vs. non-Asian) [Table 1].
In multivariate analysis, the availability of  EUS-BD 
expertise was the single independent factor that 
inf luenced patient preference (odds ratio [OR] 
3.168; 95% of  confidence interval [CI] 1.714–5.856; 
P < 0.001) [Table 2] .  Reasons for select ing 
EUS-BD included less physical discomfort without 
percutaneous drain tube placement (196/251, 78.1%), 
a higher success rate with relatively lower morbidity 
(110/251, 43.8%), and the ability to be performed 
at the same time as the ERCP (71/251, 28.3%). 
By contrast, reasons for selecting PTBD included 
proven technical safety (43/62, 69.4%), shorter 
procedure time (18/62, 29%), technical easiness 
(8/62, 12.9%), and cost-effect iveness (4/62, 
6.5%) [Figure 2].
Figure 1. Flow diagram for study
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process may simulate obtained informed consent for 
possible EUS-BD before ERCP. Since the prediction 
of  endoscopically inaccessible papilla before ERCP is 
difficult, unplanned PTBD after failed outpatient ERCP 
may occur, and it can incur additional hospitalization 
and an unexpected economic burden on patients 
and their families. Thus, we adopted an algorithm 
described in our previous studies,[16,18,26] and routinely 
obtained informed consent for EUS-BD before ERCP, 
especially in patients at potential risk of  unsuccessful 
Table 1. Baseline characteristics of patients and factors influencing the preference for EUS‑BD in 
univariate analysis
Variable Total (n=313) (%) Preferred EUS-BD (n=251) (%) Preferred PTBD (n=62) (%) P
Age (year), mean±SD 64.0±15.5 64.3±15.0 62.7±17.5
≥65 160 (51.1) 128 (51.0) 32 (51.6) 0.931
Sex
Male 182 (58.1) 149 (59.4) 33 (53.2) 0.380
Suspected diagnosis
Cholangiocarcinoma 101 (32.3) 85 (33.9) 16 (25.8) 0.469
Gallbladder cancer 25 (8.0) 22 (8.8) 3 (4.8)
Ampullary cancer 20 (6.4) 16 (6.4) 4 (6.5)
Pancreatic head cancer 93 (29.7) 71 (28.3) 22 (35.5)
Hepatocelluar carcinoma 7 (2.2) 6 (2.4) 1 (1.6)
Metastatic lymph node 5 (1.6) 5 (1.9) 0 (0.0)
Indeterminate biliary stricture 62 (19.8) 46 (18.3) 16 (25.8)
Prior experience
Prior endoscopy 258 (82.4) 212 (84.5) 46 (74.2) 0.057
Prior ERCP 163 (52.1) 132 (52.6) 31 (50.0) 0.715
Prior PTBD 55 (17.6) 42 (16.7) 13 (21.0) 0.433
Availability of EUS-BD-expertise
EUS-BD-expertise available 217 (69.3) 186 (74.1) 31 (50.0) <0.001
(Preference of EUS-BD) (100.0) (85.7) (14.3)
EUS-BD-expertise unavailable 96 (30.7) 65 (25.9) 31 (50.0)
(Preference of EUS-BD) (100.0) (67.7) (32.3)
Region
Asia 241 (77.0) 197 (78.5) 44 (71.0) 0.208
(Preference of EUS-BD) (100.0) (81.7) (18.3)
Europe 72 (23.0) 54 (21.5) 18 (29.0)
(Preference of EUS-BD) (100.0) (75.0) (25.0)
Race
Asian 242 (77.3) 198 (78.9) 44 (71.0) 0.183
(Preference of EUS-BD) (100.0) (81.8) (18.2)
Non-Asian (caucasian, hispanic) 71 (22.7) 53 (21.1) 18 (29.0)
(Preference of EUS-BD) (100.0) (74.6) (25.4)
EUS-BD: EUS-guided biliary drainage, PTBD: Percutaneous transhepatic biliary drainage, SD: Standard deviation
Table 2. Factors influencing the preference for 
EUS-guided biliary drainage in multivariate 
logistic regression analysis
Variable OR 95% CI P
Sex (male vs. female) 0.853 0.479–1.518 0.588
Age (<65 years vs. ≥65 years) 0.710 0.386–1.307 0.272
Previous endoscopy (no 
experience vs. experience)
1.887 0.955–3.728 0.068
EUS-BD-expertise availability 
(unavailable vs. available)
3.168 1.714–5.856 <0.001
OR: Odds ratio, CI: Confidence interval, EUS-BD: EUS-guided biliary 
drainage
Figure 2. Graph demonstrating the reasons behind patient preference
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cannulation. This approach allows the endoscopists to 
perform timely, one-stage BD, even in the event of  the 
unexpected inaccessible papilla, without the difficulty of  
obtaining informed consent from the sedated patient in 
the same ERCP unit.
Due to comparable safety and cost-effectiveness 
between the inpatient and outpatient procedures, many 
endoscopists perform ERCP on an outpatient basis in 
the United States.[27] However, unplanned admission 
after outpatient ERCP was reported in 10.7%–25.1% 
of  the cases.[28,29] EUS-BD has been reported to result 
in less physical discomfort[19] and fewer frequent 
unscheduled reintervention with prolonged hospital 
stays, which are associated with economic burden, 
than PTBD.[26] Thus, EUS-BD after failed ERCP in 
same endoscopic session may reduce the unplanned 
admission in the outpatient setting of  ERCP. Therefore, 
treating patients with a preference of  EUS-BD prior 
to ERCP may be more appealing to endoscopists with 
EUS-BD expertise in the United States who are able 
to perform outpatient ERCP compared with inpatient 
setting of  ERCP in other country with time availability 
of  scheduled alternative BD procedure on a different 
session in same day or next day after failed ERCP.
In the present study, age, sex, and prior experience of  
endoscopy, ERCP, and PTBD were not significantly 
associated with a preference of  EUS-BD. However, the 
preference of  EUS-BD was lower at centers without 
EUS-BD expertise compared to centers with available 
EUS-BD expert [Figure 3a]. We believe that patients 
at centers without EUS-BD expertise preferred PTBD 
over EUS-BD because it was perceived to be a safe and 
readily accessible procedure without an endoscopist with 
EUS-BD expertise or appropriate radiological/surgical 
backup. Similarly, patients at centers with EUS-BD 
expertise preferred EUS-BD over PTBD because it was 
perceived to be a comfortable and readily accessible 
endoscopic procedure. Given the close relationship 
between preference of  EUS-BD and its availability 
at their particular center, we believe that technical 
advancements and access to EUS-BD experts would 
improve patient preference and perception of  EUS-BD 
when ERCP fails.
Patient willingness to undergo EUS-BD was shown 
to increase when AE rates for EUS-BD were less 
compared to those of  PTBD (9%–33%). This suggests 
that patients may have a fundamentally favorable 
perception of  EUS-BD, regardless of  its availability 
within a given center or their preference of  PTBD. 
In a previous study, patient perception of  natural 
orifice transluminal endoscopic surgery (NOTES), 
a newly developed endoscopic technique similar to 
EUS-BD, were evaluated,[30] and the preference of  
NOTES was observed to decrease with increased 
procedural AEs when compared to a more proven 
procedure (laparoscopic cholecystectomy). Similarly, in 
our study, the preference of  EUS-BD decreased in 
accordance with an increase in AE rates of  EUS-BD 
compared to those of  PTBD. In these circumstances, 
the patient preference may be affected by the 
perception of  PTBD with proven technical safety and 
easiness.
Figure 3. Relationship between patient preference and adverse event rates for EUS‑guided biliary drainage depending on (a) the availability of 
EUS‑guided biliary drainage expertise and (b) the region
ba
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We included both Asian and European patients to 
minimize selection bias with respect to a specific 
region. In the context of  a decrease in AE rates of  
EUS-BD compared to those of  PTBD (<9%), the 
preferential tendency of  EUS-BD in Spanish patients 
was higher than that in Asian patients without statistical 
significance. However, with similar or increased AE 
rates of  EUS-BD compared with those of  PTBD, the 
preferential tendency for EUS-BD in Spanish patients 
was lower than that in Asian patients [Figure 3b]. 
Differences in the culture and health-care systems 
between Asia and Europe might have influenced 
patient preferential tendency of  EUS-BD and PTBD 
according to the degree of  AE rates in EUS-BD. 
Further investigation is necessary to understand these 
differences.
The response rate to the questionnaire was very 
high (95.7%). All of  the participants were scheduled 
to undergo ERCP for suspected malignant biliary 
obstruction. These patients showed interest in the 
detailed process of  the ERCP that they would be 
undergoing and were concerned about the need for 
any subsequent procedures in the event of  failed 
ERCP. In general, patients with suspected malignancy 
wanted to understand their disease and its treatment 
options. In a previous report, the majority of  patients 
who underwent an EUS-FNA for suspected pancreatic 
cancer wished to receive the preliminary results on the 
day of  the procedure (96.6%).[31] Similarly, we found 
that the participating patients in this study wished to 
obtain more information on the proposed procedures.
The role of  the patients are increasing in medical 
decision-making, and incorporation of  patient 
preference into treatment is recommended in the 
context of  shared decision-making.[23] It is reported that 
shared decision-making process may improve treatment 
outcome, patient adherence, quality of  care, and reduce 
costs.[21,22] Although the relationship between patient 
preference and choice of  treatment options was not 
evaluated in this study, our informational booklet may 
be useful as a patient decision aid to the patients with 
malignant biliary obstruction when ERCP fails. Further 
studies about the shared decision-making process are 
required to evaluate patient preference and treatment 
outcome.
There were limitations to this study. First, although 
we tried to provide the best available information on 
EUS-BD, our data were limited in terms of  the safety 
profile and efficacy of  EUS-BD, which impaired the 
patients’ ability to make an informed choice. For this 
reason, we evaluated patient preference according to 
whether AE rates were higher or lower than PTBD (9%–
33%). Second, we did not specifically query patients 
regarding the type of  prior endoscopy (gastroscopy vs. 
colonoscopy), ERCP (diagnostic vs. therapeutic), and 
PTBD (single vs. multiple) that they had previously 
undergone. This may have influenced patient perception 
of  EUS-BD, as their preference could have been based 
on their previous procedural experience. Third, we did 
not confirm whether the patients sufficiently grasped 
the concept of  EUS-BD. Although the informational 
booklet and questionnaire were written in an easily 
understandable language, patients with older age and a 
lower educational level might not have understood the 
questions. Finally, although the questionnaire was tested 
for internal consistency before its administration, it was 
not fully independently validated because this was a 
pilot study on patient preference. Medical students may 
not have been an accurate representation of  the general 
patient population that was scheduled to undergo BD for 
malignant biliary obstruction.
CONCLUSIONS
In this international multicenter survey, approximately 
80% of  the patients preferred EUS-BD to PTBD 
after being informed of  the benefits and risks of  both 
procedures. However, preference of  EUS-BD declined 
as its AE rates increased. Although our survey data 
are preliminary, patients had favorable perception of  
EUS-BD due to the possibility of  internal drainage 
without a percutaneous drain tube. Further technical 
innovations and improved proficiency in EUS-BD 
for reducing AEs may increase patient preference of  
EUS-BD and encourage the use of  this procedure as a 
routine clinical practice when ERCP fails.
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SUPPLEMENTARY APPENDICES
Supplementary Appendix 1
Patient perception and preference of  EUS-guided 
drainage over percutaneous drainage when endoscopic 
transpapillary biliary drainage fails: an international 
multicenter survey.
Subject: A survey for the patient perception and 
preference between draining the bile by placing a 
biliary catheter through the skin (called percutaneous 
transhepatic biliary drainage, PTBD) and draining 
the bile by the use of  endoscopy with the help 
of  ultrasonography (called EUS biliary drainage, 
EUS-BD) in patients with biliary obstruction after 
unsuccessful biliary drainage with ERCP-guided 
biliary drainage (ERCP-BD).
When obstructive jaundice occurs in patients with 
biliary obstruction, the bile is drained by the use of  
special endoscope called ERCP-BD during which 
they place a drainage catheter in the bile duct by 
passing the scope from the mouth to the small bowel 
then to the bile duct, it is considered as the first 
treatment option. Its success rate is approximately 
95%, whereas its adverse event rate ranges from 1%-
5%. If  this procedure fails due to duodenal invasion 
by tumor or prior surgery, there are two alternative 
treatment options, which are: 
1- Draining the bile by placement of  biliary drainage 
catheter through the skin (called percutaneous 
transhepatic biliary drainage, PTBD);
2- Draining the bile by another special endoscope with 
the help of  ultrasonography (called EUS- guided biliary 
drainage, EUS-BD).
1. Draining the bile by placing a biliary catheter 
through the skin (percutaneous transhepatic biliary 
drainage, PTBD)
PTBD is a procedure to drain the bile ducts through 
the skin of  a patient with obstruction in the bile duct. 
The classic biliary drainage procedure is performed by 
the use of  special screen, a special dye and an X-ray 
(called fluoroscopy). During this procedure the skin 
is injected with local anesthesia then a guide needle 
and biliary drainage catheter is inserted below the 
right 10th rib. The procedure takes about 30 minutes 
to1 hour. It is a standard treatment for benign or 
malignant obstruction in the bile duct after failed 
draining with ERCP (ERCP-BD). Its success rate 
ranges from 87% to 100%. The overall incidence of  
adverse events is about 13% (range 9%-33%). These 
adverse events include infection, bleeding, and catheter 
blockage or movement to a different location. The 
overall incidence of  severe adverse event is 8.2% 
(bile duct injury, and severe bleeding in the bile 
duct or abdominal cavity) When massive bleeding 
occurs, emergent procedure will be required such as 
closing the bleeding vessels by the radiologist with 
the use of  special dye and X-ray (called angiogram) 
or surgery. The advantage of  this procedure is high 
success rate with relatively shorter procedure time 
and it is well-established procedure (which has been 
done successfully many times in the past) after failed 
ERCP. The disadvantages of  this procedure are related 
to the draining catheter and the canal formed by this 
catheter, which is related to pain, dislodgment, and 
tract implantation with tumor in cancer patients. 
2. Endoscopic drainage of  bile with the help of  
ultrasonography (EUS‑guided biliary drainage, 
EUS‑BD)
EUS is a type of  endoscopy with an ultrasonogram 
attached to the front of  the scope. Using EUS, 
the gastroenterologist can examine the parts which 
cannot be seen with the usual endoscope. EUS 
guided biliary drainage is a newly developed procedure 
used in bile duct obstruction caused by cancer 
during which a new drainage route is made either by 
making a route between the liver and the stomach 
(called hepaticogastrostomy, EUS-HG) or  making 
a route between the bile duct and the duodenum 
(called choledochoduodenostomy, EUS-CD). It is 
a newly developed procedure, and its success rate 
ranges from 75% to 100%, which is comparable 
to draining the bile through the skin (percutaneous 
transhepatic biliary drainage, PTBD). The overall 
incidence of  adverse event ranges from 11% to 
27%. These adverse events includes leakage of  
bile to the abdominal cavity causing inflammation 
(Bile peritonitis), stent migration to a different 
location, self-limited air leak to the abdominal cavity 
(Pneumoperitoneum), and bleeding. The advantages 
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of  this procedure are that it can be done at the 
same time after failed ERCP (bile drainage through 
the skin by catheter placement PTBD is mostly 
performed in another session after failed ERCP). 
Furthermore, no external drain is required. Based on 
recent studies, the technical and clinical success rate 
and incidence of  overall adverse event is comparable 
to draining the bile through the skin (PTBD). The 
Table 1. The comparison of ERCP-BD, PTBD, EUS-
BD
ERCP-BD* PTBD* EUS-BD*
Summary Using ERCP,  
insert biliary 
drainage 
catheter from 
inside the 
small bowel
Using special 
X-ray called 
fluoroscopy to 
insert biliary 
drainage 
catheter 
through 
the skin 
Using EUS, 
make a 
new biliary 
drainage 
route (liver-
stomach, 
bile duct-
duodenum)
Procedure 
Time
30 minutes 
– 1 hour
30 minutes 
– 1 hour
Within 1 hour
Cost* (Outpatient) (Outpatient)1 
x ERCP-BD
(Outpatient) 
1.5 x ERCP-BD
Success Rate 90%-97% 87%-100% 75%-100%
Adverse 
Event Rate
<10% 9%-33%  
(Mortality 
Rate 2%-15%)
~25%
Advantages Allows 
diagnosis and 
treatment 
simultaneously. 
Bile drain 
inside 
Shorter 
procedure 
time, less 
procedure-
related pain 
Bile drain 
outside by 
catheter 
through 
the skin.
Allows 
immediate 
procedure 
after failed 
endoscopic 
procedure. 
Bile drain 
inside
Disadvantages Difficulty to 
approach 
the bile duct 
from inside 
in case of 
some cancer 
or surgically 
altered 
anatomy. 
Possibility of 
bleeding or 
infection in 
the bile duct.
Bile drains 
outside by 
catheter 
through the 
skin, some 
problems with 
drain care. 
Possibility of 
bleeding or 
infection in 
the bile duct.
Operator-
dependent 
procedure 
needs 
experiences. 
Possibility 
of infection 
in abdomen 
(peritonitis), 
stent 
migration.
*ERCP-BD, ERCP-guided biliary drainage; PTBD, percutaneous transhepatic 
biliary drainage; EUS-BD, EUS guided biliary drainage.
disadvantages of  this procedure are that it is a 
relatively new approach, which should be performed 
by an expert gastroenterologist. Thus, the overall 
success and adverse event rate may vary based on the 
gastroenterologist experience in this field. 
*Cost includes only basic procedure and additional cost 
about stent insertion is possible. 
Bile drainage by ERCP (ERCP‑BD)
Bile catheter placement through the skin (PTBD)
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Bile drainage by EUS (EUS-BD)
Patient perception and preference of  EUS-guided drainage over percutaneous drainage when endoscopic 
transpapillary biliary drainage fails: an international multicenter survey.
We will ask you some questions about your preference for draining the bile through the skin (PTBD) or by the 
use of  endoscopy with ultrasonography (EUS-BD) if  ERCP drainage fails.
Please provide the following information
- Age:  (Year of  the Birth: 19____)- Sex: Male / Female
- Race: Caucasian, Hispanic, Asian, etc (____________)
- Did you have an endoscopy before? Yes / No
- Did you have an upper endoscopy before, where they looked at your bile duct or pancreas (called ERCP) before? 
Yes / No
- Did you have bile drain placed through the skin (called PTBD) before? Yes / No
Question 1)
- If  you should choose to have a bile drain placed, after failing ERCP drainage, would you prefer the drain placed 
through the skin (PTBD) or you prefer the drainage by EUS (EUS-BD)  
(Circle one)   
a) Through the skin (PTBD)
b) By EUS (EUS-BD)  
- If  you chose to have a bile drain placed, after failing ERCP drainage, would you prefer the drainage through 
the skin (PTBD) if
(Circle all that apply)
a) It takes less time to place it (quicker) 
b) It is cheaper 
c) It is safer (lower adverse events)
d) It is more convenient (easy to perform for operator)
e) Other: ___
- If  you chose to have a bile drain placed, after failing ERCP drainage, would you prefer drainage by EUS (EUS-
BD) if
(Circle all that apply)
Supplementary Appendix 2
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a) It can be done at the same time during the ERCP, so you do not have to come back again for another procedure
b) It has a higher success rate and relatively low adverse events
c) It is comfortable, so you do not have drain tube through the skin (such as PTBD)
d) Other: ___________________________
Question 2)
Would you prefer a drain placed through the skin if,
(Choose Yes/No in each)
(a) It is safer than EUS drainage (EUS-BD)                     Yes/No
(b) It is more dangerous than EUS drainage (EUS-BD)         Yes/No
(c) It has the same risk like EUS drainage (EUS-BD)           Yes/No
Supplementary Appendix 3
The results of  pilot test for 34 medical students
Trend of  the preference for EUS-BD with varying adverse event rated for EUS-BD (n = 34)
Table 1. Preference of biliary drainage when 
ERCP fails and the reason for their preference
Total 34 (100.0%)
Prefer EUS-BD 29/34 (85.3%)
Less physical discomfort (no 
percutaneous drain tube)
26/29 (89.7%)
Higher success rate with lower morbidity 10/29 (34.5%)
One-stage procedure when ERCP failed 15/29 (51.7%)
Prefer PTBD 5/34 (14.7%)
Proven technical safety 3/5 (60.0%)
Shorter procedure time 3/5 (60.0%)
Technical easiness 2/5 (40.0%)
Low cost 0/5 (0.0%)
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